Literature DB >> 2129359

Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure.

G Schürmann1, K Schärer, A M Wingen, G Otto, C Herfarth.   

Abstract

Infantile oxalosis is the most severe form of primary hyperoxaluria type 1, an inborn metabolic disorder caused by a deficiency of the hepatic enzyme alanine: glyoxylate aminotransferase (AGT). Renal insufficiency occurs due to excessive production and renal deposits of oxalate. This report concerns a 22-month-old girl with severe type 1 primary hyperoxaluria and chronic renal failure. Liver transplantation was performed successfully as treatment of AGT deficiency. Endogenous creatinine clearance remained stable at about 10 ml/min per 1.73 m2 at 23 months after transplantation. It is suggested that liver transplantation offers potential cure of an otherwise fatal disease. However, it remains questionable if the procedure influences kidney function in the presence of advanced renal disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129359     DOI: 10.1093/ndt/5.9.825

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.

Authors:  H Ruder; G Otto; R B Schutgens; U Querfeld; R J Wanders; K H Herzog; P Wölfel; S Pomer; K Schärer; G A Rose
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

Review 2.  The role of preemptive liver transplantation in primary hyperoxaluria type 1.

Authors:  Markus J Kemper
Journal:  Urol Res       Date:  2005-11-13

Review 3.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 4.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.